paclitaxel has been researched along with Epiphora in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Etminan, M; Maberley, D; Mikelberg, F; Sodhi, M; Yeung, SN | 1 |
Contorno, T; McGwin, G; Owsley, C; Vicinanzo, MG | 1 |
Bakhski, S; Gupta, B; Kashyap, S; Meel, R; Sharma, S; Surve, A | 1 |
Estephan, FF; Jones, DV; Lin, JT; Spell, DW | 1 |
Ahmadi, MA; Booser, D; Esmaeli, B; Valero, V | 1 |
Esmaeli, B; Hortobagyi, GN | 1 |
Ahmadi, MA; Arbuckle, R; Booser, D; Delpassand, E; Esmaeli, B; Esteva, F; Hortobagyi, G; Ibrahim, N; Valero, V | 1 |
7 other study(ies) available for paclitaxel and Epiphora
Article | Year |
---|---|
Risk of Ocular Adverse Events With Taxane-Based Chemotherapy.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Bridged-Ring Compounds; Child; Docetaxel; Female; Humans; Lacrimal Apparatus Diseases; Macular Edema; Middle Aged; Optic Nerve Diseases; Paclitaxel; Retrospective Studies; Tamoxifen; Taxoids | 2022 |
The Association Between Taxane Use and Lacrimal Disorders.
Topics: Docetaxel; Humans; Lacrimal Apparatus Diseases; Paclitaxel; Taxoids; United States | 2023 |
A Rare Case of Pediatric Lacrimal Sac: Squamous Cell Carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Fine-Needle; Carboplatin; Carcinoma, Squamous Cell; Child; Eye Neoplasms; Humans; Lacrimal Apparatus Diseases; Lymphadenopathy; Male; Neoadjuvant Therapy; Paclitaxel; Tomography, X-Ray Computed | 2019 |
Epiphora induced by intermittent docetaxel (taxotere) in patients with non-small cell lung cancer.
Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Docetaxel; Humans; Lacrimal Apparatus Diseases; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Taxoids | 2003 |
Canalicular stenosis secondary to docetaxel (taxotere): a newly recognized side effect.
Topics: Adult; Antineoplastic Agents, Phytogenic; Docetaxel; Female; Fibrosis; Humans; Lacrimal Apparatus; Lacrimal Apparatus Diseases; Lacrimal Duct Obstruction; Middle Aged; Paclitaxel; Taxoids; Tears | 2001 |
Canalicular stenosis as the underlying mechanism for epiphora in patients receiving weekly docetaxel.
Topics: Antineoplastic Agents, Phytogenic; Humans; Lacrimal Apparatus Diseases; Lacrimal Duct Obstruction; Paclitaxel | 2001 |
Canalicular stenosis secondary to weekly docetaxel: a potentially preventable side effect.
Topics: Adult; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Female; Humans; Lacrimal Apparatus Diseases; Lacrimal Duct Obstruction; Middle Aged; Paclitaxel; Taxoids | 2002 |